Next 10 |
Findings presented at the ENDO 2024 conference Veracyte, Inc . (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new research findings suggesting the potential of novel molecular signatures to identify patients with thyroid nodules or cancer who have aggressive d...
Veracyte, Inc . (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that data from three studies will demonstrate the power of the Afirma GRID (Genomic Resource for Intelligent Discovery) tool to help unlock new molecular insights into thyroid tumors, which may ultimately help...
2024-05-07 20:46:09 ET Veracyte, Inc. (VCYT) Q1 2024 Earnings Conference Call May 07, 2024 04:30 PM ET Company Participants Shayla Gorman - Senior Director, Investor Relations Marc Stapley - Chief Executive Officer Rebecca Chambers - Chief Financial Officer ...
2024-05-07 17:54:38 ET Gainers: Innodata ( INOD ) +22% . Cricut ( CRCT ) +14% . ODDITY Tech ( ODD ) +14% . Cirrus Logic ( CRUS ) +11% . Veracyte ( VCYT ) +8% . Losers: Treace Medical Concepts ( TMCI ...
2024-05-07 16:17:09 ET More on Veracyte Veracyte, Inc. (VCYT) Q4 2023 Earnings Call Transcript Veracyte, Inc. 2023 Q4 - Results - Earnings Call Presentation Veracyte Q1 2024 Earnings Preview Seeking Alpha’s Quant Rating on Veracyte Historical e...
Grew total revenue to $96.8 million, an increase of 17% Grew testing revenue by 25% Conference call and webcast today at 4:30 p.m. ET Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the first quarter ended March 31, 2024. “We had a strong s...
2024-05-06 17:35:20 ET More on Veracyte Veracyte, Inc. (VCYT) Q4 2023 Earnings Call Transcript Veracyte, Inc. 2023 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Veracyte Historical earnings data for Veracyte Financia...
Large number of abstracts also showcases power of the Veracyte Diagnostics Platform Veracyte, Inc . (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that data from 14 presentations at AUA 2024, the annual meeting of the American Urological Association, show ...
2024-04-25 09:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the first quarter of 2024 after the close of market on Tuesday, May 7, 2024. Company management will host a conference call and webcast to discuss financial results and provide a general business update at ...
News, Short Squeeze, Breakout and More Instantly...
Findings presented at the ENDO 2024 conference Veracyte, Inc . (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new research findings suggesting the potential of novel molecular signatures to identify patients with thyroid nodules or cancer who have aggressive d...
Veracyte, Inc . (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that data from three studies will demonstrate the power of the Afirma GRID (Genomic Resource for Intelligent Discovery) tool to help unlock new molecular insights into thyroid tumors, which may ultimately help...
Grew total revenue to $96.8 million, an increase of 17% Grew testing revenue by 25% Conference call and webcast today at 4:30 p.m. ET Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the first quarter ended March 31, 2024. “We had a strong s...